SCHEMBL3769875

SCHEMBL3769875

CC(C)(C)OC(=O)Nc1ccc(-c2ccccc2)nc1NC(=O)c1ccc(CN(Cc2ccccn2)C(=O)O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.40
HDAC3 O15379 2/20 0.40
HDAC2 Q92769 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 2/20 0.39
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CTNNB1 P35222 1/20 0.37
TCF7L2 Q9NQB0 1/20 0.37
NAMPT P43490 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HDAC11 Q96DB2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3639824 0.92 HDAC1 (0.47) HDAC1HDAC3HDAC2NCOR2NAMPT
SCHEMBL3649530 0.87 HDAC1 (0.53) HDAC1HDAC3HDAC2NCOR2ALDH1A1
SCHEMBL3642860 0.84 HDAC1 (0.57) HDAC1HDAC3HDAC2NCOR2SMN1; SMN2
SCHEMBL3771620 0.82 HDAC1 (0.49) HDAC1HDAC3HDAC2HTTNPSR1
SCHEMBL8065436 0.81 HDAC1 (0.46) HDAC1NAMPTBRD9
SCHEMBL3648233 0.80 HDAC1 (0.54) HDAC1HDAC3HDAC2CTNNB1TCF7L2
SCHEMBL3639887 0.78 BRD9 (0.44) HDAC1NAMPTBRD9
SCHEMBL8082841 0.76 HDAC1 (0.52) HDAC1HDAC3HDAC2NCOR2MEN1
SCHEMBL3765663 0.76 HDAC1 (0.49) HDAC1HDAC3HDAC2NCOR2HTT
SCHEMBL8068427 0.74 HDAC1 (0.59) HDAC1HDAC3HDAC2NCOR2NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461189-B2 Pyridyl derivatives as histone deacetylase inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324092-A1 PYRIDYL AND PYRIMIDINYL DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS BRDT, HDAC5, HDAC1 HDAC1 3/4885HDAC3 5/4885HDAC2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.